Brian Conway
Simon Fraser University(CA)Vancouver Infectious Diseases Centre(CA)
Publications by Year
Research Areas
Hepatitis C virus research, HIV/AIDS drug development and treatment, Hepatitis B Virus Studies, HIV Research and Treatment, HIV/AIDS Research and Interventions
Most-Cited Works
- → Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection(2015)845 cited
- → Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials(2018)373 cited
- → Elbasvir–Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy(2016)362 cited
- → Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study(2014)325 cited
- → Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial(2018)286 cited
- → Barriers associated with the treatment of hepatitis C virus infection among illicit drug users(2007)190 cited